• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.
    All News #Library

    Capricor Therapeutics Sets New PDUFA Date For Deramiocel BLA

    GLOBENEWSWIRE

    BioNTech Founders To Leave Famed mRNA Biotech For New Venture

    BIOSPACE

    Neuland to Open Commercial Peptide Facility as Part of Expansion

    PHARMIWEB

    Senator Ron Launch Investigation Into FDA Rare Disease Rejection

    BIOSPACE

    CSL firms up details on $1.5B US plasma-based medicines plant

    FIERCE PHARMA

    Lilly pledges $500M to South Korea biopharma industry

    FIERCE BIOTECH

    FDA approves leucovorin for Rare Genetic Disorder Causing Autism

    REUTERS

    Novo Nordisk receives FDA warning linked to US inspection in 2025

    REUTERS

    FDA Proposes to Ease Testing to Speed Up Biosimilar Development

    REUTERS

    Xenon Seeks FDA Approval for Epilepsy Drug After Phase 3 Win

    BIOSPACE

    Ipsen Withdraws Tazverik In Lymphoma And Sarcoma

    GLOBENEWSWIRE

    Kelun-Biotech, Harbour Biomed Get NMPA Nod For SKB575/HBM7575

    PR NEWSWIRE

    Roche`s Oral SERD Flunks 1St-Line Breast Cancer Phase 3

    FIERCE BIOTECH

    FDA Expands Label For BMS` Sotyktu To Treat Psoriatic Arthritis

    FIERCE PHARMA

    AbbVie Reports Positive Ph1 Results For ABBV-295 Amylin Analog

    PRESS RELEASE

    J&J Secures Third FDA Approval For Multiple Myeloma Treatment

    BIOSPACE

    Lonza Shakes Off Capsule Business In $3B Deal With Lone Star

    FIERCE PHARMA

    Servier Bolsters Brain Cancer Portfolio in $2.5B Day One Deal

    BIOSPACE

    Granules India’s US packaging facility Passes FDA Inspection

    PRESS RELEASE

    Sanofi Sells Generics Unit To Brazil`s EMS

    PRESS RELEASE

    Viking Therapeutics Joins Investor Conferences

    PR NEWSWIRE

    INOVIO to Release Q4, FY 2025 Financials March 12

    PR NEWSWIRE

    Amgen to Present at Leerink Partners Global Healthcare Conference

    PR NEWSWIRE

    Sanofi Board Proposes Christel Heydemann As Independent Director

    PRESS RELEASE

    Iran war could disrupt India’s pharma exports by up to $500M

    ECONOMICTIMES

    Zealand`s Zupreme serves up to 10.7% mean weight loss

    GLOBENEWSWIRE

    FDA official calls UniQure`s Huntington`s disease treatment a fai

    REUTERS

    China Approves Pfizer GLP-1 Drug for Weight Loss

    REUTERS

    Zura Bio Unveils TibuSURE Design for Dual IL-17A in SSC Congress

    PHARMIWEB

    Zevra Therapeutics Appoints Justin as Chief Financial Officer

    GLOBENEWSWIRE

    Xylocor Names John Tucker as President & CEO

    PHARMIWEB

    Wave Life Sciences: Late-Breaker Oral on WVE-006 for AATD

    GLOBENEWSWIRE

    Vertex Presents JOURNAVX Data on Effective Pain Management

    PHARMIWEB

    Verrica Pharma Reports 2025 Results and Provides Corporate Update

    GLOBENEWSWIRE

    Vera Therapeutics Appoints Christopher Hite To Board of Directors

    GLOBENEWSWIRE

    Upperton Enhances Sterile Facility With MHRA Submission

    PHARMIWEB

    Uniqure, FDA Back-And-Forth Intensifies

    FIERCE BIOTECH

    Senior FDA Official Fires Back At Uniqure Amid Controversy

    FIERCE BIOTECH

    Mosaic Announces Quarterly Dividend Of $0.22 Per Share

    ACCESSWIRE

    Tevogen Advances Generics, Signs LOI with Apozeal Pharma

    GLOBENEWSWIRE

    Tango Therapeutics Reports 2025 Financial & Business Updates

    GLOBENEWSWIRE

    Swarm Oncology Appoints Bernhard Ehmer As Chairman

    GLOBENEWSWIRE

    Sonothera Showcases RIPPLE For DMD At MDA 2026

    PHARMIWEB

    Skye Bioscience To Reveal 2025 Financials And Business Update

    GLOBENEWSWIRE

    Silence Therapeutics Reports Q4 and FY2025 Results, Highlights

    PHARMIWEB

    Shattuck Labs Unveils 2025 Financials And Business Updates

    GLOBENEWSWIRE

    Seastar Medical Completes FDA Enrollment For QUELIMMUNE

    GLOBENEWSWIRE

    Revalesio Unveils RNS60 Stroke Advances at ASENT Meeting

    PR NEWSWIRE

    Repligen Corporation To Present At Upcoming March Conferences

    GLOBENEWSWIRE

    REGENXBIO Announces Q4, Full-Year 2025 Results & Highlights

    PR NEWSWIRE

    Regeneron Announces Investor Conference Presentation

    GLOBENEWSWIRE

    Rakovina Closes $1M Debenture Unit Placement & Debt Settlements

    GLOBENEWSWIRE

    Pacbio Appoints Chris Gibson To Board Of Directors

    GLOBENEWSWIRE

    Omada Health Reports Fourth Quarter And Full-Year 2025 Results

    GLOBENEWSWIRE

    Oculis To Participate In Upcoming Investor Conferences

    GLOBENEWSWIRE

    Oculis Publishes 2025 Consolidated Financial Statements

    GLOBENEWSWIRE

    Nyxoah To Report Q4 And Full Year 2025 Financial Results

    GLOBENEWSWIRE

    FDA Cites Novo Nordisk Again For Misleading GLP-1 AD

    RAPS

    Nextcure Updates Business And Releases 2025 Financials

    GLOBENEWSWIRE

    Nephros Plans Q4 2025 Financial Results Conference Call

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.